- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-03-0040080

About Pristine Pearl Pharma Private Limited
Data last updated:
Pristine Pearl Pharma Private Limited is a private limited company based in Ukkadam, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U74110TZ2014PTC021000. Its GSTIN is 33AAGCB2183C1Z6 (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It was formerly known as Pearl Labs(India) Private Limited and Pearl Laboratory Private Limited. It is led by directors including Mohamedayoob and Ummalhaseena.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at ''Palepu Palladium'' 1st Floor Kempetty Colony Selvapuram By Pass Road, Ukkadam, Tamil Nadu, India – 641001.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.51 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹57.48 Lakh (net margin 0.8%) and EBITDA of ₹2.8 Cr (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 53% over five years.
The company has about 409 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25 Cr and satisfied charges of ₹34 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
Pristine Pearl Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-03-0040080). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pristinepearl.com.
Company details
Name history
Pristine Pearl Pharma has undergone 3 name changes throughout its history. The company was previously known as Pearl Labs(India) Private Limited, Pearl Laboratory Private Limited, and Best Multispeciality Hospitals India Private Limited. The current legal name is Pristine Pearl Pharma Private Limited.
| Company Name | Status |
|---|---|
| Pristine Pearl Pharma Private Limited | Current |
| Pearl Labs(India) Private Limited | Previous |
| Pearl Laboratory Private Limited | Previous |
| Best Multispeciality Hospitals India Private Limited | Previous |
CIN history
Pristine Pearl Pharma has one previous CIN (Corporate Identification Number): U85191TZ2014PTC021000. The current CIN is U74110TZ2014PTC021000, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110TZ2014PTC021000 | Current |
| U85191TZ2014PTC021000 | Previous |
Recognitions & Rankings of Pristine Pearl Pharma
Contact details
Pristine Pearl Pharma Private Limited's registered office is in Ukkadam, Tamil Nadu. Its website is pristinepearl.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address''Palepu Palladium'' 1st Floor Kempetty Colony Selvapuram By Pass Road, Ukkadam, Tamil Nadu, India – 641001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pristine Pearl Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pristine Pearl Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pristine Pearl Pharma Private Limited, buy the company report.
Financials of Pristine Pearl Pharma Private Limited
FY 2025 filings availablePristine Pearl Pharma Private Limited reported revenue of ₹68.51 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 53%. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pristine Pearl Pharma Private Limited, buy the company report.
Board of directors of Pristine Pearl Pharma Private Limited
Pristine Pearl Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ummalhaseena | Additional Director | 25 Apr 2018 | 8 Years 6 Months | Current |
| Mohammedsirajudeen Aashikahmed Also directs: Pristine Prints Private Limited | Additional Director | 25 Apr 2018 | 8 Years 6 Months | Current |
| Mohamedayoob Also directs: Pristine Prints Private Limited | Director | 29 Dec 2014 | 11 Years 10 Months | Current |
Peer comparison
Pristine Pearl Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zelleven Lifescience Private Limited | ₹69.02 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India | |||
| Vama Lifecare Private Limited | ₹68.87 Cr (FY 2024) | 16.0% | Mumbai, Maharashtra, India | |||
| Pristine Pearl Pharma Private Limitedthis company | ₹68.51 Cr (FY 2025) | ₹57.48 Lakh | 0.8% | -6.0% | 409 | Ukkadam, Tamil Nadu, India |
| Iberia Pharmaceuticals India Limited | ₹67.39 Cr (FY 2023) | 54.0% | New Delhi, Delhi, India |
To see the full peer comparison of Pristine Pearl Pharma Private Limited, buy the company report.
Auditor
Pristine Pearl Pharma Private Limited is audited by SHANMUGAM VASUDEVAN AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHANMUGAM VASUDEVAN AND COMPANY | FY 2023 | 011627S |
Shareholding
The shareholding of Pristine Pearl Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pristine Pearl Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 May 2025 | 101108496 | Others | ₹25 Cr | Open | |
| 29 Apr 2024 | 100921018 | Others | ₹19 Cr | Satisfied | |
| 24 Dec 2021 | 100528531 | Hdfc Bank Limited | ₹15 Cr | Satisfied |
To see the full charge records of Pristine Pearl Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Pristine Pearl Pharma Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Interim or miscellaneous application | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
To see the full case history of Pristine Pearl Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pristine Pearl Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pristine Pearl Pharma Private Limited has a workforce of 409 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 409 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Pristine Pearl Pharma Private Limited, buy the company report.
GST
Pristine Pearl Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCB2183C1Z6 | Tamil Nadu | Active | 01 Jul 2017 |
| 29AAGCB2183C1ZV | Karnataka | Active | 12 Sep 2022 |
To see the full GST registrations and return filing status of Pristine Pearl Pharma Private Limited, buy the company report.
Recent activity
Pristine Pearl Pharma Private Limited has 7 board changes on record since 2014: 3 appointments and 4 cessations. The latest: Abdul Rahman Mujibur Rahman ceased to be Additional Director on 17 Oct 2022.
4 earlier events are in the company report.
Frequently asked questions
Pristine Pearl Pharma is an active private limited company based in Ukkadam, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 December 2014 (12+ years old) and is registered under CIN U74110TZ2014PTC021000.
Pristine Pearl Pharma has 3 current directors:
- Ummalhaseena - Additional Director
- Mohammedsirajudeen Aashikahmed - Additional Director
- Mohamedayoob - Director
The latest financial statements of Pristine Pearl Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pristine Pearl Pharma is 33AAGCB2183C1Z6, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAGCB2183C1ZV (Karnataka).
The CIN (Corporate Identification Number) of Pristine Pearl Pharma is U74110TZ2014PTC021000. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pristine Pearl Pharma has 3 court cases on record: 3 filed against it. 3 are pending.
Pristine Pearl Pharma was incorporated on 29 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Pristine Pearl Pharma by revenue are Zelleven Lifescience Private Limited, Vama Lifecare Private Limited, Iberia Pharmaceuticals India Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Abdul Rahman Mujibur Rahman ceased to be Additional Director on 17 Oct 2022. Kaliappan Uthayamoorthi ceased to be Additional Director on 17 Oct 2022. Muthumanikandan Muthu ceased to be Director on 17 Oct 2022. Pristine Pearl Pharma has 7 board changes on record in total.
Yes, Pristine Pearl Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-03-0040080).
Pristine Pearl Pharma can be reached through the website pristinepearl.com. Its registered office is in Ukkadam, Tamil Nadu, India.

